ロード中...
Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation
Repositioning of approved drugs for identifying new therapeutic purposes is an alternative, time and cost saving strategy to classical drug development. Here, we screened a library of 786 FDA-approved drugs to find compounds, which can potentially be repurposed for treatment of T cell-mediated autoi...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7821167/ https://ncbi.nlm.nih.gov/pubmed/33488629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.616570 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|